跳至主要内容
临床试验/ACTRN12614000289617
ACTRN12614000289617已完成4 期

A single centre nested cohort study investigating the safety and efficacy of using 0.9 % saline or Plasma-Lyte (Registered Trademark) as post-operative fluid therapy in adults undergoing cardiac surgery

Medical Research Institute of New Zealand0 个研究点目标入组 260 人开始时间: 2014年3月19日最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adult patients > 18 years
  • Elective or emergency cardiac surgery

排除标准

  • Patients who are <18 years in age
  • Patients who are expected to require renal replacement therapy within six hours of ICU admission
  • Patients who are usually on dialysis for end stage renal failure
  • Patients who are admitted to the ICU solely for consideration of organ donation or for palliative care
  • Patients previously enrolled in the SPLIT trial

研究者

相似试验